Unity prices $85M IPO

Unity Biotechnology Inc. (NASDAQ:UBX) raised $85 million late Wednesday through the sale of 5 million shares at $17 in an IPO underwritten by Goldman Sachs, Morgan Stanley, Citigroup and Mizuho. The price was at the midpoint of Unity’s proposed range of $16-$18 and values the company at $712.4 million. Unity was down $0.35 to $16.65 on Thursday.

Unity's lead candidates target senescent cells to treat age-related diseases (see BioCentury, Oct. 31, 2016)...